Sfoglia per Autore
Plasma levels of levodopa. Its main metabolites and carbidopa after conventional and slow release levodopa-carbidopa treatment in parkinsonian patients.
1990-01-01 Baraldo, Massimo; Zara, G; Benetello, P; Furlanut, Mario
FARMACOLOGIA CLINICA DELL'ENURESI PRIMARIA
1990-01-01 Montanari, G.; Baraldo, Massimo; Zara, G.; Furlanut, Mario
Side effects of imipramine therapy in enuretic children.
1990-01-01 Montanari, G; Baraldo, Massimo; Zara, G; Benetello, P; Secchieri, S; Furlanut, Mario
Chlorpromazine disposition in relation to age in children
1990-01-01 Furlanut, Mario; Benetello, P; Baraldo, Massimo; Zara, G; Montanari, G; Donzelli, F.
Imipramine pharmacokinetics in depressed geriatric patients
1990-01-01 Benetello, P; Furlanut, Mario; Zara, G; Baraldo, Massimo
Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa-carbidopa associations.
1993-01-01 Benetello, P; Furlanut, M; Zara, G; Baraldo, Massimo; Hassan, E.
CYCLOSPORINE-A (CSA) PLUS CHEMOTHERAPY (CHT) IN-VIVO, TO OVERCOME MULTIDRUG-RESISTANCE (MDR)
1993-01-01 Fanin, Renato; Damiani, Daniela; Michieli, M; Cerno, M; Michelutti, A; Baraldo, Massimo; Furlanut, Mario; Baccarani, Michele; Tura, S
Effect of fluctuations of blood cyclosporine concentrations on renal function.
1994-01-01 Furlanut, Mario; Baraldo, Massimo; Pea, Federico; Albanese4, Mariacristina4; Albertini5, Aldo5; Puricelli6, C. 6.
No effect of clodronate on cyclosporin A blood levels in heart transplant patients simultaneously treated with diltiazem and azathioprine.
1994-01-01 Baraldo, Massimo; Furlanut, Mario; Puricelli, C.
Somatomedin C (insulin-like growth factor 1) levels decrease during acute changes of stress related hormones. Relevance for fibromyalgia.
1994-01-01 Ferraccioli, Gianfranco; Guerra2, P2; Rizz3, V3; Baraldo, Massimo; Salaffi5, F5; Furlanut, Mario
CYCLOSPORINE-A PLUS CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA
1994-01-01 Fanin, Renato; Damiani, Daniela; Michieli, M; Cerno, M; Candoni, A; Michelutti, A; Baraldo, M; Russo, D; Furlanut, M.; Baccarani, M.
P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases
1995-01-01 Damiani, Daniela; Michieli2, M2; Michelutti3, A3; Pea, Federico; Baraldo, Massimo; Fanin, Renato; Russo7, D7; Furlanut, Mario; Baccarani9, Michele9
Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases
1995-01-01 Damiani, Daniela; Michieli, M.; Pea, F.; Baraldo, Massimo; Fanin, R.; Russo, D.; Furlanut, M.; Baccarani, M.
Calculating percentage prediction error: a user's note
1995-01-01 Wu, Guang; Baraldo, Massimo; Furlanut, Mario
Oral and intravenous disposition of cyclosporine in psoriatic patients.
1995-01-01 Galla, F; Marzocchi, V; Croattino, L; Poz, Donatella; Baraldo, Massimo; Furlanut, Mario
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods
1995-01-01 Wu, Guang; Baraldo, Massimo; Pea, Federico; Cossettini4, P4; Furlanut, Mario
Blood concentrations and clinical effect of cyclosporin in psoriasis
1996-01-01 Furlanut, Mario; Baraldo, Massimo; Pea, Federico; Marzocchi, V.; Croattino, L.; Galla, F.
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis
1996-01-01 Furlanut, Mario; Baraldo, Massimo; Galla3, F3; Marzocchi4, V4; Pea, Federico
Monitoraggio del Gabapentine e della Lamotrigina in pazienti con crisi parziali complesse
1997-01-01 Benetello, P.; Fortunato, M.; Tognon, A.; Testa, G. F.; Baraldo, Massimo; Pea, Federico; Furlanut, Mario
Cyclosporin nephrotoxicity in relation to its pharmacokinetics in man
1997-01-01 Furlanut, Mario; Baraldo, Massimo; Pea, Federico
Preliminary observations on serum concentrations of tamoxifen and its main metabolites in patients with breast cancer
1997-01-01 Franceschi, Loretta; Baraldo, Massimo; Pea, Federico; Cartei4, G. 4.; Furlanut, Mario
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia
1997-01-01 Damiani, Daniela; Pea, Federico; Michieli, Mariagrazia; Ermacora4, A4; Baraldo, Massimo; Russo6, D6; Fanin, Renato; Furlanut, Mario; Baccarani, Michele
Oral gabapentin disposition in patients with epilepsy after a high-protein meal
1997-01-01 Benetello, Pierpaola; Furlanut, Mario; Fortunato3, M3; Baraldo, Massimo; Pea, Federico; Tognon6, A6; Testa7, G. 7.
Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association
1997-01-01 Benetello, P.; Furlanut, Mario; Fortunato, M.; Pea, Federico; Baraldo, Massimo
Farmacocinetica di due formulazioni di ciclosporina A in pazienti dermatologici
1998-01-01 Frattasio, A; Baraldo, Massimo; Stinco, Giuseppe; Pea, F; De Francesco, V; Furlanut, M; Patrone, Pasquale
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia.
1998-01-01 Damiani, Daniela; Michieli2, M2; Ermacora3, A3; Russo4, D4; Fanin, Renato; Zaja, Francesco; Baraldo, Massimo; Pea, Federico; Furlanut, Mario; Baccarani, Michele
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia.
1999-01-01 Pea, Federico; Damiani, Daniela; Michieli3, M3; Ermacora4, A4; Baraldo, Massimo; Russo6, D6; Fanin, Renato; Baccarani, Michele; Furlanut9, Mario9
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy
1999-01-01 Baraldo, Massimo; Ferraccioli, Gianfranco; Pea, Federico; Gremese4, E4; Furlanut, Mario
Inter-patient and intra-patient variations in the baseline tapping test in patients with Parkinson's disease
1999-01-01 Wu, G.; Baraldo, Massimo; Furlanut, Mario
Pharmacokinetic profile of two different administration schemes of teicoplanin. Single 400 mg intravenous dose vs double-refracted 200 mg intramuscular doses in healthy volunteers
1999-01-01 Pea, Federico; Furlanut, Mario; Poz, Donatella; Baraldo, Massimo
Isoniazid and its hydrazine metabolite in patients with tuberculosis
1999-01-01 Pea, Federico; Milaneschi, R.; Baraldo, Massimo; Talmassons, G.; Furlanut, Mario
Optimisation of vancomycin regimen in neutropenic haematological patients with normal renal function. Multiple daily doses may be preferable
2000-01-01 Pea, Federico; Poz, Donatella; Baraldo, Massimo; Furlanut, Mario
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures
2000-01-01 Pea, Federico; Porreca2, L2; Baraldo, Massimo; Furlanut, Mario
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeutic drug monitoring
2000-01-01 Pea, Federico; Baraldo, Massimo; Lugatti, Emilio; Talmassons, Giovanni; Furlanut, Mario; Milaneschi, R
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia
2000-01-01 Pea, Federico; Russo2, D2; Michieli3, M3; Baraldo, Massimo; Ermacora5, A5; Damiani, Daniela; Baccarani, Michele; Furlanut, Mario
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis
2001-01-01 Scotton, Pg; Pea, Federico; Giobbia, M; Baraldo, Massimo; Vaglia, A; Furlanut, Mario
Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients
2001-01-01 Baraldo, Massimo; Pea, Federico; Poz3, Donatella3; Furlanut, Mario
Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients
2001-01-01 Baraldo, Massimo; Pea, Federico; Poz, D.; Albanese, M. C.; Livi, Ugolino; Furlanut, Mario
C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses.
2002-01-01 Baraldo, Massimo; Francesconi2, Anna2; Barbone, Fabio; Tursi4, Vincenzo4; Livi, Ugolino; Furlanut, Mario
Therapeutic drug monitoring of lamotrigine in patients suffering from resistant partial seizures
2002-01-01 Benetello, P.; Furlanut, Mario; Baraldo, Massimo; Tonon, A.; Furlanut, M.
GVHD and cyclosporien levels in blood in different moments after allogeneic bone marrow transplantation: an open question?
2003-01-01 Skert, C.; Damiani, Daniela; Baraldo, Massimo; Socchir, ; Tiribelli, Mario; Sperotto, A.; Brollo, L.; Fanin, R.
Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation.
2003-01-01 Baraldo, Massimo; Risaliti, Andrea; Bresadola, Fabrizio; Chiarandini, Paolo; DELLA ROCCA, Giorgio; Furlanut, Mario
AM and PM C2 monitoring of cyclosporine in liver transplant recipients
2003-01-01 Baraldo, Massimo; Pavan, F; Brollo, L; Di Qual, E; Franceschi, L; Furlanut, Mario
Limited sampling strategy for the determination of mycophenolic acid area under the curve in adult heart transplanted patients.
2005-01-01 Baraldo, Massimo; Francesconi, A.; Isola, Miriam; Feruglio, M. T.; Franceschi, L.; Tursi, V.; Livi, Ugolino; Furlanut, M.
Tossicologia Clinica
2005-01-01 Baraldo, Massimo
Pharmacokinetic of protease inhibitors based regimens in 3 liver transplantation HCV/HIV coinfected patients.
2005-01-01 By:adani, Gl; Baccarani, Umberto; Tavio, Marcello; Sainz, Mauricio; Lorenzin, Dario; Pea, Federico; Baraldo, Massimo; Bresadola, Vittorio; Risallti, A; Viale, Pierluigi; Bresadola, Fabrizio
MEZZI DI CONTRASTO
2005-01-01 Baraldo, Massimo
Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients
2005-01-01 Baraldo, Massimo; Isola, Miriam; Feruglio, Mt; Francesconi, A.; Franceschi, Loretta; Tursi, V.; Livi, Ugolino; Furlanut, Mario
Relevants of Mycophenolate mofetil therapeutic drug monitoring in heart transplantation
2006-01-01 Molinaro, M; Carazzone, C; Barbano, D; Pellegrini, C; Viganò, M; Cotrufo, M; Livi, Ugolino; Baraldo, Massimo; Furlanut, M; Vitali, E; Zoppi, F; Regazzi, M.
Relevance of Mycophenolate Mofetil Therapeutic Drug Monitorino in hearth transplantation
2006-01-01 M., Molinaro; C., Carazzone; D., Barbaro; C., Pellegrini; M., Viganò; M, Cotrufo; Livi, Ugolino; Baraldo, Massimo; M., Furlanut
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Plasma levels of levodopa. Its main metabolites and carbidopa after conventional and slow release levodopa-carbidopa treatment in parkinsonian patients. | 1-gen-1990 | Baraldo, Massimo; Zara, G; Benetello, P; Furlanut, Mario | |
FARMACOLOGIA CLINICA DELL'ENURESI PRIMARIA | 1-gen-1990 | Montanari, G.; Baraldo, Massimo; Zara, G.; Furlanut, Mario | |
Side effects of imipramine therapy in enuretic children. | 1-gen-1990 | Montanari, G; Baraldo, Massimo; Zara, G; Benetello, P; Secchieri, S; Furlanut, Mario | |
Chlorpromazine disposition in relation to age in children | 1-gen-1990 | Furlanut, Mario; Benetello, P; Baraldo, Massimo; Zara, G; Montanari, G; Donzelli, F. | |
Imipramine pharmacokinetics in depressed geriatric patients | 1-gen-1990 | Benetello, P; Furlanut, Mario; Zara, G; Baraldo, Massimo | |
Plasma levels of levodopa and its main metabolites in parkinsonian patients after conventional and controlled-release levodopa-carbidopa associations. | 1-gen-1993 | Benetello, P; Furlanut, M; Zara, G; Baraldo, Massimo; Hassan, E. | |
CYCLOSPORINE-A (CSA) PLUS CHEMOTHERAPY (CHT) IN-VIVO, TO OVERCOME MULTIDRUG-RESISTANCE (MDR) | 1-gen-1993 | Fanin, Renato; Damiani, Daniela; Michieli, M; Cerno, M; Michelutti, A; Baraldo, Massimo; Furlanut, Mario; Baccarani, Michele; Tura, S | |
Effect of fluctuations of blood cyclosporine concentrations on renal function. | 1-gen-1994 | Furlanut, Mario; Baraldo, Massimo; Pea, Federico; Albanese4, Mariacristina4; Albertini5, Aldo5; Puricelli6, C. 6. | |
No effect of clodronate on cyclosporin A blood levels in heart transplant patients simultaneously treated with diltiazem and azathioprine. | 1-gen-1994 | Baraldo, Massimo; Furlanut, Mario; Puricelli, C. | |
Somatomedin C (insulin-like growth factor 1) levels decrease during acute changes of stress related hormones. Relevance for fibromyalgia. | 1-gen-1994 | Ferraccioli, Gianfranco; Guerra2, P2; Rizz3, V3; Baraldo, Massimo; Salaffi5, F5; Furlanut, Mario | |
CYCLOSPORINE-A PLUS CHEMOTHERAPY IN ACUTE MYELOID-LEUKEMIA | 1-gen-1994 | Fanin, Renato; Damiani, Daniela; Michieli, M; Cerno, M; Candoni, A; Michelutti, A; Baraldo, M; Russo, D; Furlanut, M.; Baccarani, M. | |
P170-related multidrug resistance. Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases | 1-gen-1995 | Damiani, Daniela; Michieli2, M2; Michelutti3, A3; Pea, Federico; Baraldo, Massimo; Fanin, Renato; Russo7, D7; Furlanut, Mario; Baccarani9, Michele9 | |
Enhancement of idarubicin content in leukemic cells with cyclosporin in vivo: a report of two cases | 1-gen-1995 | Damiani, Daniela; Michieli, M.; Pea, F.; Baraldo, Massimo; Fanin, R.; Russo, D.; Furlanut, M.; Baccarani, M. | |
Calculating percentage prediction error: a user's note | 1-gen-1995 | Wu, Guang; Baraldo, Massimo; Furlanut, Mario | |
Oral and intravenous disposition of cyclosporine in psoriatic patients. | 1-gen-1995 | Galla, F; Marzocchi, V; Croattino, L; Poz, Donatella; Baraldo, Massimo; Furlanut, Mario | |
Effects of different sampling strategies on predictions of blood cyclosporine concentrations in haematological patients with multidrug resistance by Bayesian and non-linear least squares methods | 1-gen-1995 | Wu, Guang; Baraldo, Massimo; Pea, Federico; Cossettini4, P4; Furlanut, Mario | |
Blood concentrations and clinical effect of cyclosporin in psoriasis | 1-gen-1996 | Furlanut, Mario; Baraldo, Massimo; Pea, Federico; Marzocchi, V.; Croattino, L.; Galla, F. | |
Cyclosporin nephrotoxicity in relation to its metabolism in psoriasis | 1-gen-1996 | Furlanut, Mario; Baraldo, Massimo; Galla3, F3; Marzocchi4, V4; Pea, Federico | |
Monitoraggio del Gabapentine e della Lamotrigina in pazienti con crisi parziali complesse | 1-gen-1997 | Benetello, P.; Fortunato, M.; Tognon, A.; Testa, G. F.; Baraldo, Massimo; Pea, Federico; Furlanut, Mario | |
Cyclosporin nephrotoxicity in relation to its pharmacokinetics in man | 1-gen-1997 | Furlanut, Mario; Baraldo, Massimo; Pea, Federico | |
Preliminary observations on serum concentrations of tamoxifen and its main metabolites in patients with breast cancer | 1-gen-1997 | Franceschi, Loretta; Baraldo, Massimo; Pea, Federico; Cartei4, G. 4.; Furlanut, Mario | |
Multidrug resistance modulation in vivo. The effect of cyclosporin alone or with dextro-verapamil on idarubicin pharmacokinetics in acute leukemia | 1-gen-1997 | Damiani, Daniela; Pea, Federico; Michieli, Mariagrazia; Ermacora4, A4; Baraldo, Massimo; Russo6, D6; Fanin, Renato; Furlanut, Mario; Baccarani, Michele | |
Oral gabapentin disposition in patients with epilepsy after a high-protein meal | 1-gen-1997 | Benetello, Pierpaola; Furlanut, Mario; Fortunato3, M3; Baraldo, Massimo; Pea, Federico; Tognon6, A6; Testa7, G. 7. | |
Levodopa and 3-O-methyldopa in cerebrospinal fluid after levodopa-carbidopa association | 1-gen-1997 | Benetello, P.; Furlanut, Mario; Fortunato, M.; Pea, Federico; Baraldo, Massimo | |
Farmacocinetica di due formulazioni di ciclosporina A in pazienti dermatologici | 1-gen-1998 | Frattasio, A; Baraldo, Massimo; Stinco, Giuseppe; Pea, F; De Francesco, V; Furlanut, M; Patrone, Pasquale | |
Adjuvant treatment with cyclosporin A increases the toxicity of chemotherapy for remission induction in acute non-lymphocytic leukemia. | 1-gen-1998 | Damiani, Daniela; Michieli2, M2; Ermacora3, A3; Russo4, D4; Fanin, Renato; Zaja, Francesco; Baraldo, Massimo; Pea, Federico; Furlanut, Mario; Baccarani, Michele | |
Multidrug resistance modulation in vivo: the effect of cyclosporin A alone or with dexverapamil on idarubicin pharmacokinetics in acute leukemia. | 1-gen-1999 | Pea, Federico; Damiani, Daniela; Michieli3, M3; Ermacora4, A4; Baraldo, Massimo; Russo6, D6; Fanin, Renato; Baccarani, Michele; Furlanut9, Mario9 | |
Cyclosporine A pharmacokinetics in rheumatoid arthritis patients after 6 months of methotrexate therapy | 1-gen-1999 | Baraldo, Massimo; Ferraccioli, Gianfranco; Pea, Federico; Gremese4, E4; Furlanut, Mario | |
Inter-patient and intra-patient variations in the baseline tapping test in patients with Parkinson's disease | 1-gen-1999 | Wu, G.; Baraldo, Massimo; Furlanut, Mario | |
Pharmacokinetic profile of two different administration schemes of teicoplanin. Single 400 mg intravenous dose vs double-refracted 200 mg intramuscular doses in healthy volunteers | 1-gen-1999 | Pea, Federico; Furlanut, Mario; Poz, Donatella; Baraldo, Massimo | |
Isoniazid and its hydrazine metabolite in patients with tuberculosis | 1-gen-1999 | Pea, Federico; Milaneschi, R.; Baraldo, Massimo; Talmassons, G.; Furlanut, Mario | |
Optimisation of vancomycin regimen in neutropenic haematological patients with normal renal function. Multiple daily doses may be preferable | 1-gen-2000 | Pea, Federico; Poz, Donatella; Baraldo, Massimo; Furlanut, Mario | |
High vancomycin dosage regimens required by intensive care unit patients cotreated with drugs to improve haemodynamics following cardiac surgical procedures | 1-gen-2000 | Pea, Federico; Porreca2, L2; Baraldo, Massimo; Furlanut, Mario | |
Ciprofloxacin disposition in elderly patients with LRTI being treated with sequential therapy (200 mg intravenously twice daily followed by 500 mg per os twice daily): Comparative pharmacokinetics and the role of therapeutic drug monitoring | 1-gen-2000 | Pea, Federico; Baraldo, Massimo; Lugatti, Emilio; Talmassons, Giovanni; Furlanut, Mario; Milaneschi, R | |
Liposomal daunorubicin plasmatic and renal disposition in patients with acute leukemia | 1-gen-2000 | Pea, Federico; Russo2, D2; Michieli3, M3; Baraldo, Massimo; Ermacora5, A5; Damiani, Daniela; Baccarani, Michele; Furlanut, Mario | |
Cerebrospinal fluid penetration of levofloxacin in patients with spontaneous acute bacterial meningitis | 1-gen-2001 | Scotton, Pg; Pea, Federico; Giobbia, M; Baraldo, Massimo; Vaglia, A; Furlanut, Mario | |
Pharmacokinetics of two oral cyclosporin a formulations in clinically stable heart-transplant patients | 1-gen-2001 | Baraldo, Massimo; Pea, Federico; Poz3, Donatella3; Furlanut, Mario | |
Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients | 1-gen-2001 | Baraldo, Massimo; Pea, Federico; Poz, D.; Albanese, M. C.; Livi, Ugolino; Furlanut, Mario | |
C(2) monitoring of cyclosporine in stable heart transplant patients after two daily and three daily doses. | 1-gen-2002 | Baraldo, Massimo; Francesconi2, Anna2; Barbone, Fabio; Tursi4, Vincenzo4; Livi, Ugolino; Furlanut, Mario | |
Therapeutic drug monitoring of lamotrigine in patients suffering from resistant partial seizures | 1-gen-2002 | Benetello, P.; Furlanut, Mario; Baraldo, Massimo; Tonon, A.; Furlanut, M. | |
GVHD and cyclosporien levels in blood in different moments after allogeneic bone marrow transplantation: an open question? | 1-gen-2003 | Skert, C.; Damiani, Daniela; Baraldo, Massimo; Socchir, ; Tiribelli, Mario; Sperotto, A.; Brollo, L.; Fanin, R. | |
Circadian variations in cyclosporine C2 concentrations during the first 2 weeks after liver transplantation. | 1-gen-2003 | Baraldo, Massimo; Risaliti, Andrea; Bresadola, Fabrizio; Chiarandini, Paolo; DELLA ROCCA, Giorgio; Furlanut, Mario | |
AM and PM C2 monitoring of cyclosporine in liver transplant recipients | 1-gen-2003 | Baraldo, Massimo; Pavan, F; Brollo, L; Di Qual, E; Franceschi, L; Furlanut, Mario | |
Limited sampling strategy for the determination of mycophenolic acid area under the curve in adult heart transplanted patients. | 1-gen-2005 | Baraldo, Massimo; Francesconi, A.; Isola, Miriam; Feruglio, M. T.; Franceschi, L.; Tursi, V.; Livi, Ugolino; Furlanut, M. | |
Tossicologia Clinica | 1-gen-2005 | Baraldo, Massimo | |
Pharmacokinetic of protease inhibitors based regimens in 3 liver transplantation HCV/HIV coinfected patients. | 1-gen-2005 | By:adani, Gl; Baccarani, Umberto; Tavio, Marcello; Sainz, Mauricio; Lorenzin, Dario; Pea, Federico; Baraldo, Massimo; Bresadola, Vittorio; Risallti, A; Viale, Pierluigi; Bresadola, Fabrizio | |
MEZZI DI CONTRASTO | 1-gen-2005 | Baraldo, Massimo | |
Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients | 1-gen-2005 | Baraldo, Massimo; Isola, Miriam; Feruglio, Mt; Francesconi, A.; Franceschi, Loretta; Tursi, V.; Livi, Ugolino; Furlanut, Mario | |
Relevants of Mycophenolate mofetil therapeutic drug monitoring in heart transplantation | 1-gen-2006 | Molinaro, M; Carazzone, C; Barbano, D; Pellegrini, C; Viganò, M; Cotrufo, M; Livi, Ugolino; Baraldo, Massimo; Furlanut, M; Vitali, E; Zoppi, F; Regazzi, M. | |
Relevance of Mycophenolate Mofetil Therapeutic Drug Monitorino in hearth transplantation | 1-gen-2006 | M., Molinaro; C., Carazzone; D., Barbaro; C., Pellegrini; M., Viganò; M, Cotrufo; Livi, Ugolino; Baraldo, Massimo; M., Furlanut |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile